Haemonetics(DE:HAZ)
€104.00-1.00 (-0.95%)
DE:HAZ
Haemonetics Revenue
€104.00
At close:-1.00 (-0.95%)
Haemonetics (HAZ) Revenue
1 Followers
Haemonetics Revenue
Haemonetics had a revenue of 357.76M in the quarter ending Sep 30, 2026, with 5.42%. This bring the company's revenue in the last twelve months to 1.38B, Increased 2.25%. In the fiscal year ending Mar 31, 2026, Haemonetics had annual revenue of 1.33B with -1.97% growth.
- Revenue (ttm)
- 1.38B
- Revenue Growth
- -1.20%
- P/S Ratio
- 3.76
- Revenue/Employee
- EUR 443,346
- Employees
- 3,009
- Market Cap
- EUR 5.02B
Revenue Chart
Haemonetics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.33B | -26.80M | -1.97% |
| Mar 31, 2025 | 1.36B | 51.77M | 3.95% |
| Mar 31, 2024 | 1.31B | 140.40M | 12.01% |
| Mar 31, 2023 | 1.17B | 175.46M | 17.67% |
| Mar 31, 2022 | 993.20M | 122.73M | 14.10% |
| Mar 31, 2021 | 870.46M | -118.02M | -11.94% |
| Mar 31, 2020 | 988.48M | 20.90M | 2.16% |
| Mar 31, 2019 | 967.58M | 63.66M | 7.04% |
| Mar 31, 2018 | 903.92M | 17.81M | 2.01% |
| Mar 31, 2017 | 886.12M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.